Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Burger

Showing results (251-260 of 305) with videos related to

Pageof 31
Sort By:
Acta Physiologica (Oxford, England)|July 27, 2016
Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cellsJ-L Pan, D-Z Yuan, Y-B Zhao, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Effects of subfertility cause, smoking and body weight on the success rate of IVFA M E Lintsen, P C M Pasker-de Jong, E J de Boer, et al.
The Journal of Pathology|January 5, 2013
Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progressionMarten van der Zee, Yundan Jia, Yongyi Wang, et al.
Plos One|August 1, 2012
Identification of quiescent, stem-like cells in the distal female reproductive tractYongyi Wang, Andrea Sacchetti, Matthijs R van Dijk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2009
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinomaC G Gerestein, M J C Eijkemans, D de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patientsP M L H Vencken, M Kriege, D Hoogwerf, et al.
Molecular Endocrinology (Baltimore, Md.)|April 29, 2006
Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcriptionMaria Georgiakaki, Nathalie Chabbert-Buffet, Boris Dasen, et al.
Journal of Molecular Endocrinology|December 16, 2006
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell lineP Hanifi-Moghaddam, B Sijmons, M C Ott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 10, 2014
Progesterone-induced cyclin G1 inhibits the proliferation of endometrial epithelial cell and its possible molecular mechanismD-z Yuan, X-l Ding, H-l Yu, et al.
Clinical Endocrinology|May 14, 2016
Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancerE T Massolt, M van der Windt, T I M Korevaar, et al.
Pageof 31

Showing results (251-260 of 305) with videos related to

Sort By:
Pageof 31
Acta Physiologica (Oxford, England)|July 27, 2016
Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cellsJ-L Pan, D-Z Yuan, Y-B Zhao, et al.
Human Reproduction (Oxford, England)|April 9, 2005
Effects of subfertility cause, smoking and body weight on the success rate of IVFA M E Lintsen, P C M Pasker-de Jong, E J de Boer, et al.
The Journal of Pathology|January 5, 2013
Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progressionMarten van der Zee, Yundan Jia, Yongyi Wang, et al.
Plos One|August 1, 2012
Identification of quiescent, stem-like cells in the distal female reproductive tractYongyi Wang, Andrea Sacchetti, Matthijs R van Dijk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 4, 2009
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinomaC G Gerestein, M J C Eijkemans, D de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patientsP M L H Vencken, M Kriege, D Hoogwerf, et al.
Molecular Endocrinology (Baltimore, Md.)|April 29, 2006
Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcriptionMaria Georgiakaki, Nathalie Chabbert-Buffet, Boris Dasen, et al.
Journal of Molecular Endocrinology|December 16, 2006
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell lineP Hanifi-Moghaddam, B Sijmons, M C Ott, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 10, 2014
Progesterone-induced cyclin G1 inhibits the proliferation of endometrial epithelial cell and its possible molecular mechanismD-z Yuan, X-l Ding, H-l Yu, et al.
Clinical Endocrinology|May 14, 2016
Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancerE T Massolt, M van der Windt, T I M Korevaar, et al.
Pageof 31